Grifols, S.A. (GRF)
Healthcare • Drug Manufacturers - General
StockMCESpainES0171996087
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Grifols, S.A., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in EUR. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:16. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 11:00 | — | — | — | Upcoming |
| 27 Jul 2026 20:00 | 0.24 | 0.15 | -38.1% | Miss |
| 28 Jul 2025 18:00 | 0.24 | 0.19 | -18.9% | Miss |
| 30 Jul 2024 14:00 | 0.14 | 0.14 | -1.9% | Miss |
| 27 Jul 2023 08:00 | 0.13 | 0.09 | -29.0% | Miss |
| 27 Feb 2022 19:00 | 0.22 | -0.06 | -127.3% | Miss |
| 29 Jul 2021 08:00 | 0.23 | 0.24 | +0.7% | In line |
| 04 May 2021 01:00 | 0.19 | 0.17 | -11.1% | Miss |
| 26 Feb 2021 18:00 | 0.19 | 0.24 | +25.7% | Beat |
| 05 Nov 2020 02:00 | 0.26 | 0.32 | +23.6% | Beat |
| 30 Jul 2020 08:00 | 0.07 | 0.31 | +341.6% | Beat |
| 21 Apr 2020 08:00 | 0.26 | 0.22 | -14.6% | Miss |
| 27 Feb 2020 15:00 | 0.32 | 0.28 | -12.9% | Miss |
| 29 Oct 2019 03:00 | 0.28 | 0.25 | -8.3% | Miss |
| 31 Jul 2019 03:00 | 0.28 | 0.29 | +2.8% | Beat |
| 07 May 2019 05:00 | 0.22 | 0.22 | -2.0% | Miss |
| 28 Feb 2019 02:00 | 0.27 | 0.21 | -20.1% | Miss |
| 05 Nov 2018 05:00 | 0.26 | 0.26 | -3.0% | Miss |
| 27 Jul 2018 02:00 | 0.26 | 0.29 | +9.3% | Beat |
| 03 May 2018 02:00 | 0.23 | 0.24 | +1.7% | Beat |
| 28 Feb 2018 03:00 | 0.25 | 0.24 | -5.6% | Miss |
| 02 Nov 2017 03:00 | 0.25 | 0.24 | -2.9% | Miss |
| 28 Jul 2017 03:00 | 0.27 | 0.24 | -9.0% | Miss |
| 03 May 2017 02:00 | 0.24 | 0.25 | +0.8% | In line |
| 28 Feb 2017 02:00 | 0.22 | 0.24 | +9.3% | Beat |
| 08 Nov 2016 02:00 | 0.23 | 0.25 | +11.1% | Beat |
| 28 Jul 2016 06:00 | 0.22 | 0.23 | +6.1% | Beat |
| 05 May 2016 03:00 | 0.21 | 0.20 | -1.7% | Miss |
| 29 Feb 2016 03:00 | 0.27 | 0.22 | -17.2% | Miss |
| 04 Nov 2015 06:00 | 0.23 | 0.24 | +4.1% | Beat |
| 30 Jul 2015 01:00 | 0.21 | 0.22 | +2.4% | Beat |
| 07 May 2015 06:00 | 0.21 | 0.22 | +3.2% | Beat |
| 26 Feb 2015 08:00 | 0.23 | 0.24 | +4.1% | Beat |
| 04 Nov 2014 02:00 | 0.21 | 0.21 | -0.3% | In line |
| 31 Jul 2014 01:00 | 0.23 | 0.21 | -9.2% | Miss |
| 06 May 2014 16:00 | 0.20 | 0.21 | +9.7% | Beat |
| 27 Feb 2014 09:00 | 0.16 | 0.16 | +4.9% | Beat |
| 05 Nov 2013 14:00 | 0.14 | 0.13 | -13.5% | Miss |
| 31 Jul 2013 01:00 | 0.15 | 0.17 | +9.3% | Beat |
| 02 May 2013 15:00 | 0.10 | 0.17 | +65.9% | Beat |
| 01 Mar 2013 06:00 | 0.15 | 0.10 | -30.5% | Miss |
| 31 Oct 2012 09:00 | 0.12 | 0.11 | -11.8% | Miss |
| 31 Jul 2012 13:00 | 0.14 | 0.11 | -17.1% | Miss |
| 15 May 2012 14:00 | 0.10 | 0.12 | +26.3% | Beat |
| 28 Feb 2012 07:00 | 0.13 | — | -103.7% | — |
| 11 Nov 2011 07:00 | 0.14 | 0.06 | -57.8% | Miss |
| 28 Jul 2011 19:00 | 0.09 | -0.03 | -134.6% | Miss |
| 04 May 2011 20:00 | 0.10 | 0.07 | -30.0% | Miss |
| 24 Feb 2011 07:00 | 0.09 | 0.04 | -52.9% | Miss |
| 20 Dec 2010 12:00 | 0.09 | 0.07 | -15.9% | Miss |
Annual results · EUR
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 7.5B | +4.3% | 402M | 5.3% | 0.59 | +156.5% | 624M |
| 2024 | 7.2B | +9.4% | 157M | 2.2% | 0.23 | +155.6% | 530M |
| 2023 | 6.6B | +8.7% | 42M | 0.6% | 0.09 | -71.0% | -93M |
| 2022 | 6.1B | — | 185M | 3.1% | 0.31 | — | -394.3M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 11.00 | 11.71 | 10.82 | 11.63 | +5.92% | 22,262,659 | |
| Oct 2026 | 9.48 | 10.98 | 9.41 | 10.98 | +14.92% | 35,301,468 | |
| Sep 2026 | 9.83 | 10.12 | 9.23 | 9.55 | -2.87% | 26,433,839 | |
| Aug 2026 | 10.10 | 10.32 | 9.62 | 9.83 | -1.32% | 25,378,952 | |
| Jul 2026 | 8.96 | 10.81 | 8.75 | 9.96 | +11.21% | 49,021,050 | |
| Jun 2026 | 9.40 | 9.45 | 8.78 | 8.96 | -3.45% | 39,782,707 | 0.0824 |
| May 2026 | 9.05 | 9.84 | 8.62 | 9.28 | +3.57% | 66,086,012 | |
| Apr 2026 | 9.30 | 9.66 | 8.68 | 8.96 | +0.04% | 53,059,247 | |
| Mar 2026 | 10.31 | 10.75 | 8.43 | 8.96 | -15.75% | 57,798,737 | |
| Feb 2026 | 10.77 | 11.44 | 10.15 | 10.63 | -1.48% | 33,210,340 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in EUR, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Grifols (BME:GRF) Stock Price Trails Q3 Results As Debt Questions Linger (opens in a new tab) Simply Wall St. · 03 Nov 2026 19:11
- Grifols Beats Q3 Revenue Forecasts as Immunoglobulin Demand Supports Profit Growth (opens in a new tab) InvestorsHub · 03 Nov 2026 11:17
- Grifols SA (GRFS) Q3 2026 Earnings Call Highlights: Biopharma Growth Accelerates as Margin ... (opens in a new tab) GuruFocus.com · 03 Nov 2026 05:03
- Grifols (GRFS) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 03 Nov 2026 03:58
- Grifols Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 02 Nov 2026 20:12
- Grifols Q3 revenue exceeds estimates as immunoglobulin sales drive growth (opens in a new tab) Investing.com · 02 Nov 2026 18:20
- Grifols (BME:GRF) Stock Still Looks Cheap Based On Current Earnings (opens in a new tab) Simply Wall St. · 27 Oct 2026 06:07
- Plasma Demand Supports Grifols, S.A.’s (GRFS) Path Back to Financial Strength (opens in a new tab) Insider Monkey · 23 Oct 2026 15:35
- Are Options Traders Betting on a Big Move in Grifols Stock? (opens in a new tab) Zacks · 07 Oct 2026 13:54
- Grifols (BME:GRF) Stock May Be Below Fair Value On Earnings (opens in a new tab) Simply Wall St. · 26 Sep 2026 16:14
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 11.66 EUR
- Market cap
- 7.9B
- Dividend yield
- 0.69%
- 5-year average yield
- 1.33%
- Payout ratio
- 12%
- Last dividend
- 0.1500 EUR · 02 Dec 2026
- Next ex-dividend date
- 02 Dec 2026
- Exchange
- MCE
- Country
- Spain
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
Dividends
| Ex-dividend date | Per share |
|---|---|
| 30 Jun 2026 | 0.0824 EUR |
| 11 Aug 2025 | 0.1500 EUR |
| 03 Jun 2021 | 0.3643 EUR |
| 26 Oct 2020 | 0.1616 EUR |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow GRF and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.